(Polyalkoxy)sulfonate surface modifiers
AssigneesBaxter International Inc., Baxter Healthcare S.A.
InventorsJames Kipp, Ton Hai, Bennett Melnick
Life of this patent
Estimating the term…
Loading patent…
AssigneesBaxter International Inc., Baxter Healthcare S.A.
InventorsJames Kipp, Ton Hai, Bennett Melnick
Estimating the term…
The present invention is directed to novel compounds, methods of manufacture and methods of use. The present invention is also directed to solid drug/active agent particles having one or more of the compounds of the present invention associated with the surface thereof. The compounds of the present invention are comprised of a non-polar polyether covalently linked to an anionic sulfonate group. The compounds have an amphipathic quality and preferably, are surface active. Such compounds are preferably useful as surface-active agents to coat and stabilize dispersions of particles in a continuous liquid medium. These surface-active agents may be applied in the stabilization of suspensions, emulsions, or liposome formulations intended for pharmaceutical, medical, cosmetic, or agricultural use. The particles that can be prepared by a variety of methods and will preferably comprise a pharmaceutical agent. Pharmaceutical compositions of the present invention can be used to treat a myriad of conditions and can be administered by many routes, including intravenous, intramuscular, subcutaneous, intrathecal, subdural, intracameral, intracerebral, intralesional, topical, oral, buccal, rectal, transcutaneous, pulmonary, and nasal.
A compound of Formula 1:
Dependencies are inferred from the claim text.